Grid mapping study for atrial fibrillation ablation
Part of Heart & circulation clinical trials.
This trial tests a new mapping tool to help doctors find and treat the source of atrial fibrillation (AF) during a standard ablation procedure. It may offer a more precise way to guide treatment for people with AF that comes and goes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have been diagnosed with paroxysmal (coming and going) atrial fibrillation, confirmed by an ECG.
- You are scheduled to have a heart mapping and ablation procedure to treat your AF.
- You are willing to follow all study steps, including tests before and after the procedure.
- You cannot have other serious heart conditions like persistent AF, blood clots, or recent heart surgery or stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new 3D heart-mapping system that helps doctors navigate during a procedure to treat paroxysmal atrial fibrillation (a type of irregular heartbeat that can come and go). The system uses pressure and star-mapping technologies to make the treatment more precise and safer.
This trial compares two ways of guiding a procedure to treat atrial fibrillation (an irregular heartbeat). One uses special sound waves to see inside the heart, and the other uses electrical mapping. Both are used with the FARAPULSE system to deliver a type of energy called pulsed fields to fixed areas of the heart.
This study tests a new catheter to treat atrial fibrillation (AF), a heart rhythm problem, in people with symptoms. It aims to see if the treatment is safe and works well for people whose AF comes and goes.
This trial tests whether a “virtual” computer map created from your heart scans can help doctors do catheter ablation to treat atrial fibrillation (AF). It aims to improve the procedure for people whose AF symptoms were not controlled well with anti-arrhythmia medicines.
This study tests a new mapping system that helps doctors see the electrical signals in your heart more clearly during a standard ablation for persistent atrial fibrillation. It may improve the accuracy of the treatment.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
Hear when a new Paroxysmal Atrial Fibrillation (PAF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.